Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.
Journal: Oncotarget
Published: July 10, 2024
EphrinB2: Expression of a novel potential target in renal cell carcinoma.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India
Published: March 10, 2023
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2022
EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy.
Journal: Pathology, research and practice
Published: January 30, 2020
Showing 1-5 of 5
Last Updated: 09/26/2026